- Home
- BIDU vs INM Comparison
BIDU vs INM Comparison
Compare BIDU & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIDU
- INM
- Stock Information
- Founded
- BIDU 2000
- INM 1981
- Country
- BIDU China
- INM Canada
- Employees
- BIDU N/A
- INM N/A
- Industry
- BIDU Computer Software: Programming Data Processing
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- BIDU Technology
- INM Health Care
- Exchange
- BIDU Nasdaq
- INM Nasdaq
- Market Cap
- BIDU 29.1B
- INM 3.2M
- IPO Year
- BIDU 2005
- INM N/A
- Fundamental
- Price
- BIDU $89.50
- INM $2.98
- Analyst Decision
- BIDU Buy
- INM
- Analyst Count
- BIDU 11
- INM 0
- Target Price
- BIDU $116.09
- INM N/A
- AVG Volume (30 Days)
- BIDU 5.2M
- INM 55.8K
- Earning Date
- BIDU 05-21-2025
- INM 05-13-2025
- Dividend Yield
- BIDU N/A
- INM N/A
- EPS Growth
- BIDU 19.61
- INM N/A
- EPS
- BIDU 9.04
- INM N/A
- Revenue
- BIDU $18,238,549,935.00
- INM $4,832,013.00
- Revenue This Year
- BIDU $5.05
- INM N/A
- Revenue Next Year
- BIDU $5.86
- INM N/A
- P/E Ratio
- BIDU $9.91
- INM N/A
- Revenue Growth
- BIDU N/A
- INM N/A
- 52 Week Low
- BIDU $74.71
- INM $1.72
- 52 Week High
- BIDU $116.25
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- BIDU 54.29
- INM 60.92
- Support Level
- BIDU $82.00
- INM $2.56
- Resistance Level
- BIDU $84.68
- INM $3.15
- Average True Range (ATR)
- BIDU 3.60
- INM 0.28
- MACD
- BIDU 0.72
- INM 0.09
- Stochastic Oscillator
- BIDU 96.73
- INM 88.11
About BIDU Baidu Inc. ADS
Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2023. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.